Viz.ai, a developer of artificial intelligence (AI)–powered disease detection and intelligent care coordination technolo ...

Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its n ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United ...

The true incidence of RTAD has not yet been established, but it is an increasingly observed phenomenon, with an estimated overall incidence of 1% to 4%. 3-6 In their recent systematic meta-analysis, ...

In 2014, Penumbra broke into the peripheral thrombectomy space with the release of the first Indigo System catheters, the 5-F CAT5 catheter and the 3-F CAT3 catheter (Penumbra, Inc.). These were ...

Dr. Scott J. Cameron shares insights in venous thrombus biology, and Drs. Labib Haddad and Octavio Cosme present case reports using the FlowTriever and ClotTriever systems after unsuccessful ...

Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.

Chronic limb-threatening ischemia (CLTI) is a challenging disease to treat, requiring a tailored approach and comprehensive endovascular toolbox. The goal of treatment is to achieve wound healing, ...

Chronic cerebrospinal venous insufficiency (CCSVI) is a hemodynamic condition in which cerebrospinal venous drainage is altered and inhibited. Outflow obstructions of the internal jugular veins (IJVs) ...

Venous stenting first emerged as a treatment for iliofemoral venous outflow obstruction in the 1990s. Recently, several factors have led to a significant increase in the volume of these procedures ...

Pelvic venous congestion syndrome is most commonly recognized as the persistence of noncyclical chronic pelvic pain for longer than 6 months in the absence of known pelvic pathology. In the presence ...